Opinion Review
Copyright ©The Author(s) 2023.
World J Gastroenterol. Feb 7, 2023; 29(5): 773-779
Published online Feb 7, 2023. doi: 10.3748/wjg.v29.i5.773
Table 1 Practice-oriented answers to clinical questions on the management of gastro-esophageal reflux disease
No.
Question
Answer
1Should I perform endoscopy in all patients with GERD symptoms?Endoscopy should be reserved for patients with GERD symptoms and either alarm features or multiple risk factors for Barrett’s esophagus
2Is erosive esophagitis specific for diagnosis of GERD?Only LA grade C and D esophagitis are always specific for GERD
3When to perform esophageal biopsies in patients with GERD symptoms?Esophageal biopsies should be performed only when eosinophilic esophagitis is suspected
4Should hiatal hernia always be identified and measured?Hiatal hernia should always be identified and measured
5Should patients with erosive esophagitis undergo repeat endoscopy after treatment?Only patients with LA grade C and D esophagitis should undergo repeat endoscopy after PPI therapy
6Is an instrumental finding of laryngitis a specific sign of GERD?Laryngoscopic findings of laryngitis are not specific signs of GERD
7Is pH monitoring alone inferior to impedance-pH monitoring to diagnose GERD?Impedance-pH monitoring is the test of choice to confirm or rule out GERD
8How should I manage PPI therapy before impedance-pH monitoring?The choice of performing impedance-pH monitoring off-PPI or on-PPI depends on the clinical goal
9When should I verify patient adherence to PPI therapy?Adherence to PPI therapy should be always verified in case of PPI-refractory symptoms
10When do I refer a patient with PPI-refractory symptoms to anti-reflux surgery?Only patients with PPI-refractory GERD confirmed by impedance-pH monitoring should be referred to surgical fundoplication
11Which is the role for prokinetics in patients with GERD?Prokinetics may be used in patients with GERD and concomitant dyspeptic symptoms
12Which is the role for P-CABs in patients with GERD?P-CABs are promising antisecretory drugs, however more evidence is needed